{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:31:34Z","timestamp":1787495494297,"version":"build-2736575974"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,7]]},"DOI":"10.7759\/cureus.93999","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T08:08:54Z","timestamp":1759824534000},"source":"Crossref","is-referenced-by-count":4,"title":["Induced Pluripotent Stem Cells (iPSC) and Their Use in Disease Modeling"],"prefix":"10.7759","author":[{"given":"Alicja","family":"Dorota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Maryniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Mariankowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cezary","family":"Milczarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Dorota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Zywiec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol","family":"Kozlowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Illia","family":"Koval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartosz","family":"Czyzewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Czyzewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Induced pluripotential stem cells \u2014 perspectives of clinical application in cardiovascular diseases [article in Polish]","volume":"68","author":"Kolanowski T","year":"2010","unstructured":"Kolanowski T, Kurpisz M. Induced pluripotential stem cells \u2014 perspectives of clinical application in cardiovascular diseases [article in Polish]. Kardiol Pol. 2010, 68:412-17.","journal-title":"Kardiol Pol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.15283\/ijsc23148","article-title":"Inducing pluripotency in somatic cells: historical perspective and recent advances","volume":"17","author":"Park J","year":"2024","unstructured":"Park J, Kim J, Shin B, Sch Ler HR, Kim J, Kim KP. Inducing pluripotency in somatic cells: historical perspective and recent advances. Int J Stem Cells. 2024, 17:363-73. 10.15283\/ijsc23148","journal-title":"Int J Stem Cells"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi K","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006, 126:663-76. 10.1016\/j.cell.2006.07.024","journal-title":"Cell"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2010.06.004","article-title":"Reprogramming of T cells from human peripheral blood","volume":"7","author":"Loh YH","year":"2010","unstructured":"Loh YH, Hartung O, Li H, et al.. Reprogramming of T cells from human peripheral blood. Cell Stem Cell. 2010, 7:15-9. 10.1016\/j.stem.2010.06.004","journal-title":"Cell Stem Cell"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4172\/2161-0460.1000275","article-title":"Blood derived induced pluripotent stem cells (iPSCs): benefits, challenges and the road ahead","volume":"6","author":"El Hokayem J","year":"2016","unstructured":"El Hokayem J, Cukier HN, Dykxhoorn DM. Blood derived induced pluripotent stem cells (iPSCs): benefits, challenges and the road ahead. J Alzheimers Dis Parkinsonism. 2016, 6:275. 10.4172\/2161-0460.1000275","journal-title":"J Alzheimers Dis Parkinsonism"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-021-00594-5","article-title":"Urine-derived induced pluripotent\/neural stem cells for modeling neurological diseases","volume":"11","author":"Shi T","year":"2021","unstructured":"Shi T, Cheung M. Urine-derived induced pluripotent\/neural stem cells for modeling neurological diseases. Cell Biosci. 2021, 11:85. 10.1186\/s13578-021-00594-5","journal-title":"Cell Biosci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2019.07.016","article-title":"Reprogramming of urine-derived renal epithelial cells into iPSCs using srRNA and consecutive differentiation into beating cardiomyocytes","volume":"17","author":"Steinle H","year":"2019","unstructured":"Steinle H, Weber M, Behring A, et al.. Reprogramming of urine-derived renal epithelial cells into iPSCs using srRNA and consecutive differentiation into beating cardiomyocytes. Mol Ther Nucleic Acids. 2019, 17:907-21. 10.1016\/j.omtn.2019.07.016","journal-title":"Mol Ther Nucleic Acids"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2012.115","article-title":"Generation of human induced pluripotent stem cells from urine samples","volume":"7","author":"Zhou T","year":"2012","unstructured":"Zhou T, Benda C, Dunzinger S, et al.. Generation of human induced pluripotent stem cells from urine samples. Nat Protoc. 2012, 7:2080-9. 10.1038\/nprot.2012.115","journal-title":"Nat Protoc"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/768391","article-title":"A comparative view on human somatic cell sources for iPSC generation","volume":"2014","author":"Raab S","year":"2014","unstructured":"Raab S, Klingenstein M, Liebau S, Linta L. A comparative view on human somatic cell sources for iPSC generation. Stem Cells Int. 2014, 2014:768391. 10.1155\/2014\/768391","journal-title":"Stem Cells Int"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2009.0314","article-title":"iPS cells reprogrammed from human mesenchymal-like stem\/progenitor cells of dental tissue origin","volume":"19","author":"Yan X","year":"2010","unstructured":"Yan X, Qin H, Qu C, Tuan RS, Shi S, Huang GT. iPS cells reprogrammed from human mesenchymal-like stem\/progenitor cells of dental tissue origin. Stem Cells Dev. 2010, 19:469-80. 10.1089\/scd.2009.0314","journal-title":"Stem Cells Dev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s40139-013-0039-2","article-title":"Induced pluripotent stem cells as a source of hepatocytes","volume":"2","author":"Sauer V","year":"2014","unstructured":"Sauer V, Roy-Chowdhury N, Guha C, Roy-Chowdhury J. Induced pluripotent stem cells as a source of hepatocytes. Curr Pathobiol Rep. 2014, 2:11-20. 10.1007\/s40139-013-0039-2","journal-title":"Curr Pathobiol Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2217\/epi-2016-0032","article-title":"Transcriptional and epigenetic mechanisms of cellular reprogramming to induced pluripotency","volume":"8","author":"van den Hurk M","year":"2016","unstructured":"van den Hurk M, Kenis G, Bardy C, van den Hove DL, Gage FH, Steinbusch HW, Rutten BP. Transcriptional and epigenetic mechanisms of cellular reprogramming to induced pluripotency. Epigenomics. 2016, 8:1131-49. 10.2217\/epi-2016-0032","journal-title":"Epigenomics"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgg.2015.10.001","article-title":"The epigenetic reprogramming roadmap in generation of iPSCs from somatic cells","volume":"42","author":"Brix J","year":"2015","unstructured":"Brix J, Zhou Y, Luo Y. The epigenetic reprogramming roadmap in generation of iPSCs from somatic cells. J Genet Genomics. 2015, 42:661-70. 10.1016\/j.jgg.2015.10.001","journal-title":"J Genet Genomics"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/pcmedi\/pbac004","article-title":"Tumorigenicity risk of iPSCs in vivo: nip it in the bud","volume":"5","author":"Zhong C","year":"2022","unstructured":"Zhong C, Liu M, Pan X, Zhu H. Tumorigenicity risk of iPSCs in vivo: nip it in the bud. Precis Clin Med. 2022, 5:pbac004. 10.1093\/pcmedi\/pbac004","journal-title":"Precis Clin Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s12015-015-9619-3","article-title":"A comparative view on easy to deploy non-integrating methods for patient-specific iPSC production","volume":"11","author":"Manzini S","year":"2015","unstructured":"Manzini S, Viiri LE, Marttila S, Aalto-Set\u00e4l\u00e4 K. A comparative view on easy to deploy non-integrating methods for patient-specific iPSC production. Stem Cell Rev Rep. 2015, 11:900-8. 10.1007\/s12015-015-9619-3","journal-title":"Stem Cell Rev Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2008.01.004","article-title":"Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells","volume":"2","author":"Brambrink T","year":"2008","unstructured":"Brambrink T, Foreman R, Welstead GG, Lengner CJ, Wernig M, Suh H, Jaenisch R. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell. 2008, 2:151-9. 10.1016\/j.stem.2008.01.004","journal-title":"Cell Stem Cell"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17040594","article-title":"Rationale and methodology of reprogramming for generation of induced pluripotent stem cells and induced neural progenitor cells","volume":"17","author":"Tian Z","year":"2016","unstructured":"Tian Z, Guo F, Biswas S, Deng W. Rationale and methodology of reprogramming for generation of induced pluripotent stem cells and induced neural progenitor cells. Int J Mol Sci. 2016, 17:594. 10.3390\/ijms17040594","journal-title":"Int J Mol Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2015.06.001","article-title":"Combined negative effect of donor age and time in culture on the reprogramming efficiency into induced pluripotent stem cells","volume":"15","author":"Trokovic R","year":"2015","unstructured":"Trokovic R, Weltner J, Noisa P, Raivio T, Otonkoski T. Combined negative effect of donor age and time in culture on the reprogramming efficiency into induced pluripotent stem cells. Stem Cell Res. 2015, 15:254-62. 10.1016\/j.scr.2015.06.001","journal-title":"Stem Cell Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/genes9010039","article-title":"Age-related epigenetic derangement upon reprogramming and differentiation of cells from the elderly","volume":"9","author":"Ravaioli F","year":"2018","unstructured":"Ravaioli F, Bacalini MG, Franceschi C, Garagnani P. Age-related epigenetic derangement upon reprogramming and differentiation of cells from the elderly. Genes (Basel). 2018, 9:39. 10.3390\/genes9010039","journal-title":"Genes (Basel)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/stem.2899","article-title":"Epigenetic enzymes, age, and ancestry regulate the efficiency of human iPSC reprogramming","volume":"36","author":"Mackey LC","year":"2018","unstructured":"Mackey LC, Annab LA, Yang J, et al.. Epigenetic enzymes, age, and ancestry regulate the efficiency of human iPSC reprogramming. Stem Cells. 2018, 36:1697-708. 10.1002\/stem.2899","journal-title":"Stem Cells"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9036","article-title":"Limiting replication stress during somatic cell reprogramming reduces genomic instability in induced pluripotent stem cells","volume":"6","author":"Ruiz S","year":"2015","unstructured":"Ruiz S, Lopez-Contreras AJ, Gabut M, et al.. Limiting replication stress during somatic cell reprogramming reduces genomic instability in induced pluripotent stem cells. Nat Commun. 2015, 6:8036. 10.1038\/ncomms9036","journal-title":"Nat Commun"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2022.01.019","article-title":"A call for consensus guidelines on monitoring the integrity of nuclear and mitochondrial genomes in human pluripotent stem cells","volume":"17","author":"Rossi A","year":"2022","unstructured":"Rossi A, Lickfett S, Martins S, Prigione A. A call for consensus guidelines on monitoring the integrity of nuclear and mitochondrial genomes in human pluripotent stem cells. Stem Cell Reports. 2022, 17:707-10. 10.1016\/j.stemcr.2022.01.019","journal-title":"Stem Cell Reports"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-025-07658-z","article-title":"Defined culture conditions robustly maintain human stem cell pluripotency, highlighting a role for Ca(2+) signaling","volume":"8","author":"Eidhof I","year":"2025","unstructured":"Eidhof I, Ulfenborg B, Kele M, Shahsavani M, Winn D, Uhl\u00e9n P, Falk A. Defined culture conditions robustly maintain human stem cell pluripotency, highlighting a role for Ca(2+) signaling. Commun Biol. 2025, 8:255. 10.1038\/s42003-025-07658-z","journal-title":"Commun Biol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.89724","article-title":"Complete suspension culture of human induced pluripotent stem cells supplemented with suppressors of spontaneous differentiation","volume":"12","author":"Matsuo-Takasaki M","year":"2024","unstructured":"Matsuo-Takasaki M, Kambayashi S, Hemmi Y, et al.. Complete suspension culture of human induced pluripotent stem cells supplemented with suppressors of spontaneous differentiation. Elife. 2024, 12:RP89724. 10.7554\/eLife.89724","journal-title":"Elife"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-18400-8","article-title":"Improving the differentiation potential of pluripotent stem cells by optimizing culture conditions","volume":"12","author":"Yamamoto T","year":"2022","unstructured":"Yamamoto T, Arita M, Kuroda H, Suzuki T, Kawamata S. Improving the differentiation potential of pluripotent stem cells by optimizing culture conditions. Sci Rep. 2022, 12:14147. 10.1038\/s41598-022-18400-8","journal-title":"Sci Rep"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s10616-014-9815-z","article-title":"A reliable and economical method for gaining mouse embryonic fibroblasts capable of preparing feeder layers","volume":"68","author":"Jiang G","year":"2016","unstructured":"Jiang G, Wan X, Wang M, Zhou J, Pan J, Wang B. A reliable and economical method for gaining mouse embryonic fibroblasts capable of preparing feeder layers. Cytotechnology. 2016, 68:1603-14. 10.1007\/s10616-014-9815-z","journal-title":"Cytotechnology"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3791\/3854","article-title":"Preparation of mouse embryonic fibroblast cells suitable for culturing human embryonic and induced pluripotent stem cells","author":"Jozefczuk J","year":"2012","unstructured":"Jozefczuk J, Drews K, Adjaye J. Preparation of mouse embryonic fibroblast cells suitable for culturing human embryonic and induced pluripotent stem cells. J Vis Exp. 2012, 10.3791\/3854","journal-title":"J Vis Exp"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-012-9914-8","article-title":"Substrates and supplements for hESCs: a critical review","volume":"30","author":"Crocco MC","year":"2013","unstructured":"Crocco MC, Fratnz N, Bos-Mikich A. Substrates and supplements for hESCs: a critical review. J Assist Reprod Genet. 2013, 30:315-23. 10.1007\/s10815-012-9914-8","journal-title":"J Assist Reprod Genet"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.1593","article-title":"Chemically defined conditions for human iPSC derivation and culture","volume":"8","author":"Chen G","year":"2011","unstructured":"Chen G, Gulbranson DR, Hou Z, et al.. Chemically defined conditions for human iPSC derivation and culture. Nat Methods. 2011, 8:424-9. 10.1038\/nmeth.1593","journal-title":"Nat Methods"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2013.12.005","article-title":"Human pluripotent stem cell culture: considerations for maintenance, expansion, and therapeutics","volume":"14","author":"Chen KG","year":"2014","unstructured":"Chen KG, Mallon BS, McKay RD, Robey PG. Human pluripotent stem cell culture: considerations for maintenance, expansion, and therapeutics. Cell Stem Cell. 2014, 14:13-26. 10.1016\/j.stem.2013.12.005","journal-title":"Cell Stem Cell"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1177\/2050312120966456","article-title":"Long-term single-cell passaging of human iPSC fully supports pluripotency and high-efficient trilineage differentiation capacity","volume":"8","author":"Cruvinel E","year":"2020","unstructured":"Cruvinel E, Ogusuku I, Cerioni R, et al.. Long-term single-cell passaging of human iPSC fully supports pluripotency and high-efficient trilineage differentiation capacity. SAGE Open Med. 2020, 8:2050312120966456. 10.1177\/2050312120966456","journal-title":"SAGE Open Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3390\/cells11050799","article-title":"Improving cell recovery: Freezing and thawing optimization of induced pluripotent stem cells","volume":"11","author":"Uhrig M","year":"2022","unstructured":"Uhrig M, Ezquer F, Ezquer M. Improving cell recovery: Freezing and thawing optimization of induced pluripotent stem cells. Cells. 2022, 11:799. 10.3390\/cells11050799","journal-title":"Cells"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-31206-0_2","article-title":"Genomic instability of iPSCs and challenges in their clinical applications","volume":"1201","author":"Yoshihara M","year":"2019","unstructured":"Yoshihara M, Oguchi A, Murakawa Y. Genomic instability of iPSCs and challenges in their clinical applications. Adv Exp Med Biol. 2019, 1201:23-47. 10.1007\/978-3-030-31206-0_2","journal-title":"Adv Exp Med Biol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R113.516419","article-title":"Genomic instability in pluripotent stem cells: implications for clinical applications","volume":"289","author":"Peterson SE","year":"2014","unstructured":"Peterson SE, Loring JF. Genomic instability in pluripotent stem cells: implications for clinical applications. J Biol Chem. 2014, 289:4578-84. 10.1074\/jbc.R113.516419","journal-title":"J Biol Chem"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2013.12.050","article-title":"A defined xeno-free and feeder-free culture system for the derivation, expansion and direct differentiation of transgene-free patient-specific induced pluripotent stem cells","volume":"35","author":"Lu HF","year":"2014","unstructured":"Lu HF, Chai C, Lim TC, et al.. A defined xeno-free and feeder-free culture system for the derivation, expansion and direct differentiation of transgene-free patient-specific induced pluripotent stem cells. Biomaterials. 2014, 35:2816-26. 10.1016\/j.biomaterials.2013.12.050","journal-title":"Biomaterials"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1007\/s11626-010-9297-z","article-title":"Comparison of defined culture systems for feeder cell free propagation of human embryonic stem cells","volume":"46","author":"Akopian V","year":"2010","unstructured":"Akopian V, Andrews PW, Beil S, et al.. Comparison of defined culture systems for feeder cell free propagation of human embryonic stem cells. In Vitro Cell Dev Biol Anim. 2010, 46:247-58. 10.1007\/s11626-010-9297-z","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-022-02879-z","article-title":"Development and evaluation of a novel xeno-free culture medium for human-induced pluripotent stem cells","volume":"13","author":"Hua Y","year":"2022","unstructured":"Hua Y, Yoshimochi K, Li J, et al.. Development and evaluation of a novel xeno-free culture medium for human-induced pluripotent stem cells. Stem Cell Res Ther. 2022, 13:223. 10.1186\/s13287-022-02879-z","journal-title":"Stem Cell Res Ther"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1093\/stmcls\/sxac020","article-title":"Human induced pluripotent stem cells: from cell origin, genomic stability, and epigenetic memory to translational medicine","volume":"40","author":"Poetsch MS","year":"2022","unstructured":"Poetsch MS, Strano A, Guan K. Human induced pluripotent stem cells: from cell origin, genomic stability, and epigenetic memory to translational medicine. Stem Cells. 2022, 40:546-55. 10.1093\/stmcls\/sxac020","journal-title":"Stem Cells"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2013.07.001","article-title":"Genetic and epigenetic variations in iPSCs: potential causes and implications for application","volume":"13","author":"Liang G","year":"2013","unstructured":"Liang G, Zhang Y. Genetic and epigenetic variations in iPSCs: potential causes and implications for application. Cell Stem Cell. 2013, 13:149-59. 10.1016\/j.stem.2013.07.001","journal-title":"Cell Stem Cell"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1124\/pr.116.013003","article-title":"Patient and disease-specific induced pluripotent stem cells for discovery of personalized cardiovascular drugs and therapeutics","volume":"72","author":"Paik DT","year":"2020","unstructured":"Paik DT, Chandy M, Wu JC. Patient and disease-specific induced pluripotent stem cells for discovery of personalized cardiovascular drugs and therapeutics. Pharmacol Rev. 2020, 72:320-42. 10.1124\/pr.116.013003","journal-title":"Pharmacol Rev"},{"key":"ref41","doi-asserted-by":"crossref","DOI":"10.32607\/20758251-2010-2-2-18-27","article-title":"Induced pluripotent stem cells: problems and advantages when applying them in regenerative medicine","volume":"2","author":"Medvedev SP","year":"2010","unstructured":"Medvedev SP, Shevchenko AI, Zakian SM. Induced pluripotent stem cells: problems and advantages when applying them in regenerative medicine. Acta Naturae. 2010, 2:18-28.","journal-title":"Acta Naturae"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-019-0468-3","article-title":"Modeling Alzheimer's disease with iPSC-derived brain cells","volume":"25","author":"Penney J","year":"2020","unstructured":"Penney J, Ralvenius WT, Tsai LH. Modeling Alzheimer's disease with iPSC-derived brain cells. Mol Psychiatry. 2020, 25:148-67. 10.1038\/s41380-019-0468-3","journal-title":"Mol Psychiatry"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26083774","article-title":"Current development of iPSC-based modeling in neurodegenerative diseases","volume":"26","author":"Guo X","year":"2025","unstructured":"Guo X, Wang X, Wang J, Ma M, Ren Q. Current development of iPSC-based modeling in neurodegenerative diseases. Int J Mol Sci. 2025, 26:3774. 10.3390\/ijms26083774","journal-title":"Int J Mol Sci"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-014-8867-6","article-title":"Induced pluripotent stem cells for disease modeling and drug discovery in neurodegenerative diseases","volume":"52","author":"Cao L","year":"2015","unstructured":"Cao L, Tan L, Jiang T, Zhu XC, Yu JT. Induced pluripotent stem cells for disease modeling and drug discovery in neurodegenerative diseases. Mol Neurobiol. 2015, 52:244-55. 10.1007\/s12035-014-8867-6","journal-title":"Mol Neurobiol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci11030373","article-title":"Modelling Parkinson\u2019s disease: iPSCs towards better understanding of human pathology","volume":"11","author":"Avazzadeh S","year":"2021","unstructured":"Avazzadeh S, Baena JM, Keighron C, Feller-Sanchez Y, Quinlan LR. Modelling Parkinson\u2019s disease: iPSCs towards better understanding of human pathology. Brain Sci. 2021, 11:373. 10.3390\/brainsci11030373","journal-title":"Brain Sci"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12526","article-title":"Modeling Parkinson's disease with induced pluripotent stem cells harboring \u03b1-synuclein mutations","volume":"27","author":"Singh Dolt K","year":"2017","unstructured":"Singh Dolt K, Hammachi F, Kunath T. Modeling Parkinson's disease with induced pluripotent stem cells harboring \u03b1-synuclein mutations. Brain Pathol. 2017, 27:545-51. 10.1111\/bpa.12526","journal-title":"Brain Pathol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-012-0270-y","article-title":"Modeling Parkinson's disease using induced pluripotent stem cells","volume":"12","author":"Byers B","year":"2012","unstructured":"Byers B, Lee HL, Reijo Pera R. Modeling Parkinson's disease using induced pluripotent stem cells. Curr Neurol Neurosci Rep. 2012, 12:237-42. 10.1007\/s11910-012-0270-y","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26114984","article-title":"Induced pluripotent stem cells in cardiomyopathy: advancing disease modeling, therapeutic development, and regenerative therapy","volume":"26","author":"Vo QD","year":"2025","unstructured":"Vo QD, Nakamura K, Saito Y, Akagi S, Miyoshi T, Yuasa S. Induced pluripotent stem cells in cardiomyopathy: advancing disease modeling, therapeutic development, and regenerative therapy. Int J Mol Sci. 2025, 26:4984. 10.3390\/ijms26114984","journal-title":"Int J Mol Sci"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2024.103443","article-title":"Generation of induced pluripotent stem cell lines from patients with LQT1 caused by heterozygous mutations in the KCNQ1 gene","volume":"78","author":"Ren L","year":"2024","unstructured":"Ren L, Jahng JW, Belbachir N, Cook Z, Rivero GC, Perez MV, Wu JC. Generation of induced pluripotent stem cell lines from patients with LQT1 caused by heterozygous mutations in the KCNQ1 gene. Stem Cell Res. 2024, 78:103443. 10.1016\/j.scr.2024.103443","journal-title":"Stem Cell Res"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.134368","article-title":"In vitro model of ischemic heart failure using human induced pluripotent stem cell-derived cardiomyocytes","volume":"6","author":"Davis J","year":"2021","unstructured":"Davis J, Chouman A, Creech J, et al.. In vitro model of ischemic heart failure using human induced pluripotent stem cell-derived cardiomyocytes. JCI Insight. 2021, 6:e134368. 10.1172\/jci.insight.134368","journal-title":"JCI Insight"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.114.300556","article-title":"Induced pluripotent stem cells for post-myocardial infarction repair: remarkable opportunities and challenges","volume":"114","author":"Lalit PA","year":"2014","unstructured":"Lalit PA, Hei DJ, Raval AN, Kamp TJ. Induced pluripotent stem cells for post-myocardial infarction repair: remarkable opportunities and challenges. Circ Res. 2014, 114:1328-45. 10.1161\/CIRCRESAHA.114.300556","journal-title":"Circ Res"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvx125","article-title":"Human induced pluripotent stem cell-derived vascular smooth muscle cells: differentiation and therapeutic potential","volume":"113","author":"Ayoubi S","year":"2017","unstructured":"Ayoubi S, Sheikh SP, Eskildsen TV. Human induced pluripotent stem cell-derived vascular smooth muscle cells: differentiation and therapeutic potential. Cardiovasc Res. 2017, 113:1282-93. 10.1093\/cvr\/cvx125","journal-title":"Cardiovasc Res"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.973496","article-title":"Strategies to improve the therapeutic effect of pluripotent stem cell-derived cardiomyocytes on myocardial infarction","volume":"10","author":"Xiao Y","year":"2022","unstructured":"Xiao Y, Chen Y, Shao C, Wang Y, Hu S, Lei W. Strategies to improve the therapeutic effect of pluripotent stem cell-derived cardiomyocytes on myocardial infarction. Front Bioeng Biotechnol. 2022, 10:973496. 10.3389\/fbioe.2022.973496","journal-title":"Front Bioeng Biotechnol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaa125","article-title":"Human-induced pluripotent stem cells for modelling metabolic perturbations and impaired bioenergetics underlying cardiomyopathies","volume":"117","author":"Ramachandra CJ","year":"2021","unstructured":"Ramachandra CJ, Chua J, Cong S, Kp MM, Shim W, Wu JC, Hausenloy DJ. Human-induced pluripotent stem cells for modelling metabolic perturbations and impaired bioenergetics underlying cardiomyopathies. Cardiovasc Res. 2021, 117:694-711. 10.1093\/cvr\/cvaa125","journal-title":"Cardiovasc Res"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.07.062","article-title":"Functional gene correction for cystic fibrosis in lung epithelial cells generated from patient iPSCs","volume":"12","author":"Firth AL","year":"2015","unstructured":"Firth AL, Menon T, Parker GS, et al.. Functional gene correction for cystic fibrosis in lung epithelial cells generated from patient iPSCs. Cell Rep. 2015, 12:1385-90. 10.1016\/j.celrep.2015.07.062","journal-title":"Cell Rep"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2328","article-title":"Directed differentiation of human pluripotent stem cells into mature airway epithelia expressing functional CFTR protein","volume":"30","author":"Wong AP","year":"2012","unstructured":"Wong AP, Bear CE, Chin S, et al.. Directed differentiation of human pluripotent stem cells into mature airway epithelia expressing functional CFTR protein. Nat Biotechnol. 2012, 30:876-82. 10.1038\/nbt.2328","journal-title":"Nat Biotechnol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00465.2017","article-title":"Personalized medicine in CF: from modulator development to therapy for cystic fibrosis patients with rare CFTR mutations","volume":"314","author":"Harutyunyan M","year":"2018","unstructured":"Harutyunyan M, Huang Y, Mun KS, Yang F, Arora K, Naren AP. Personalized medicine in CF: from modulator development to therapy for cystic fibrosis patients with rare CFTR mutations. Am J Physiol Lung Cell Mol Physiol. 2018, 314:L529-43. 10.1152\/ajplung.00465.2017","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.3791\/59432","article-title":"CRISPR\/Cas9 technology in restoring dystrophin expression in iPSC-derived muscle progenitors","author":"Jin Y","year":"2019","unstructured":"Jin Y, Shen Y, Su X, Weintraub N, Tang Y. CRISPR\/Cas9 technology in restoring dystrophin expression in iPSC-derived muscle progenitors. J Vis Exp. 2019, e59432. 10.3791\/59432","journal-title":"J Vis Exp"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2020.03.012","article-title":"Effective restoration of dystrophin expression in iPSC (Mdx)-derived muscle progenitor cells using the CRISPR\/Cas9 system and homology-directed repair technology","volume":"18","author":"Jin Y","year":"2020","unstructured":"Jin Y, Shen Y, Su X, Weintraub NL, Tang Y. Effective restoration of dystrophin expression in iPSC (Mdx)-derived muscle progenitor cells using the CRISPR\/Cas9 system and homology-directed repair technology. Comput Struct Biotechnol J. 2020, 18:765-73. 10.1016\/j.csbj.2020.03.012","journal-title":"Comput Struct Biotechnol J"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.4172\/2157-7633.1000361","article-title":"Induced pluripotent stem cells derived muscle progenitors effectively mitigate muscular dystrophy through restoring the dystrophin distribution","volume":"6","author":"Cai WF","year":"2016","unstructured":"Cai WF, Huang W, Wang L, et al.. Induced pluripotent stem cells derived muscle progenitors effectively mitigate muscular dystrophy through restoring the dystrophin distribution. J Stem Cell Res Ther. 2016, 6:1000361. 10.4172\/2157-7633.1000361","journal-title":"J Stem Cell Res Ther"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2020.102079","article-title":"Generation of two induced pluripotent stem cell lines from a female adult homozygous for the Wilson disease associated ATP7B variant p.H1069Q (AKOSi008-A) and a healthy control (AKOSi009-A)","volume":"49","author":"Petters J","year":"2020","unstructured":"Petters J, V\u00f6lkner C, Krohn S, et al.. Generation of two induced pluripotent stem cell lines from a female adult homozygous for the Wilson disease associated ATP7B variant p.H1069Q (AKOSi008-A) and a healthy control (AKOSi009-A). Stem Cell Res. 2020, 49:102079. 10.1016\/j.scr.2020.102079","journal-title":"Stem Cell Res"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddac080","article-title":"Retinoids rescue ceruloplasmin secretion and alleviate oxidative stress in Wilson's disease-specific hepatocytes","volume":"31","author":"Song D","year":"2022","unstructured":"Song D, Takahashi G, Zheng YW, et al.. Retinoids rescue ceruloplasmin secretion and alleviate oxidative stress in Wilson's disease-specific hepatocytes. Hum Mol Genet. 2022, 31:3652-71. 10.1093\/hmg\/ddac080","journal-title":"Hum Mol Genet"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddr223","article-title":"Rescue of ATP7B function in hepatocyte-like cells from Wilson's disease induced pluripotent stem cells using gene therapy or the chaperone drug curcumin","volume":"20","author":"Zhang S","year":"2011","unstructured":"Zhang S, Chen S, Li W, et al.. Rescue of ATP7B function in hepatocyte-like cells from Wilson's disease induced pluripotent stem cells using gene therapy or the chaperone drug curcumin. Hum Mol Genet. 2011, 20:3176-87. 10.1093\/hmg\/ddr223","journal-title":"Hum Mol Genet"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.3390\/jcm4061193","article-title":"The possible future roles for iPSC-derived therapy for autoimmune diseases","volume":"4","author":"Hew M","year":"2015","unstructured":"Hew M, O'Connor K, Edel MJ, Lucas M. The possible future roles for iPSC-derived therapy for autoimmune diseases. J Clin Med. 2015, 4:1193-206. 10.3390\/jcm4061193","journal-title":"J Clin Med"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1089\/scd.2020.0194","article-title":"Generation of systemic lupus erythematosus patient-derived induced pluripotent stem cells from blood","volume":"30","author":"Li W","year":"2021","unstructured":"Li W, Liu D, Zheng F, et al.. Generation of systemic lupus erythematosus patient-derived induced pluripotent stem cells from blood. Stem Cells Dev. 2021, 30:227-33. 10.1089\/scd.2020.0194","journal-title":"Stem Cells Dev"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2012.190","article-title":"Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors","volume":"9","author":"Bottini N","year":"2013","unstructured":"Bottini N, Firestein GS. Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nat Rev Rheumatol. 2013, 9:24-33. 10.1038\/nrrheum.2012.190","journal-title":"Nat Rev Rheumatol"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00958","article-title":"C-reactive protein promotes the activation of fibroblast-like synoviocytes from patients with rheumatoid arthritis","volume":"11","author":"Fang Z","year":"2020","unstructured":"Fang Z, Lv J, Wang J, et al.. C-reactive protein promotes the activation of fibroblast-like synoviocytes from patients with rheumatoid arthritis. Front Immunol. 2020, 11:958. 10.3389\/fimmu.2020.00958","journal-title":"Front Immunol"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2020.101958","article-title":"Generation of iPSC-derived insulin-producing cells from patients with type 1 and type 2 diabetes compared with healthy control","volume":"48","author":"Kim MJ","year":"2020","unstructured":"Kim MJ, Lee EY, You YH, Yang HK, Yoon KH, Kim JW. Generation of iPSC-derived insulin-producing cells from patients with type 1 and type 2 diabetes compared with healthy control. Stem Cell Res. 2020, 48:101958. 10.1016\/j.scr.2020.101958","journal-title":"Stem Cell Res"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.737276","article-title":"Use of induced pluripotent stem cells to build isogenic systems and investigate type 1 diabetes","volume":"12","author":"Armitage LH","year":"2021","unstructured":"Armitage LH, Stimpson SE, Santostefano KE, et al.. Use of induced pluripotent stem cells to build isogenic systems and investigate type 1 diabetes. Front Endocrinol (Lausanne). 2021, 12:737276. 10.3389\/fendo.2021.737276","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0233980","article-title":"iPSCs from people with MS can differentiate into oligodendrocytes in a homeostatic but not an inflammatory milieu","volume":"15","author":"Morales Pantoja IE","year":"2020","unstructured":"Morales Pantoja IE, Smith MD, Rajbhandari L, et al.. iPSCs from people with MS can differentiate into oligodendrocytes in a homeostatic but not an inflammatory milieu. PLoS One. 2020, 15:e0233980. 10.1371\/journal.pone.0233980","journal-title":"PLoS One"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1002\/glia.22769","article-title":"Human oligodendrocytes in remyelination research","volume":"63","author":"Czepiel M","year":"2015","unstructured":"Czepiel M, Boddeke E, Copray S. Human oligodendrocytes in remyelination research. Glia. 2015, 63:513-30. 10.1002\/glia.22769","journal-title":"Glia"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.18103\/mra.v11i11.4784","article-title":"The challenges to advancing induced pluripotent stem cell-dependent cell replacement therapy","volume":"11","author":"Moy AB","year":"2023","unstructured":"Moy AB, Kamath A, Ternes S, Kamath J. The challenges to advancing induced pluripotent stem cell-dependent cell replacement therapy. Med Res Arch. 2023, 11:4784. 10.18103\/mra.v11i11.4784","journal-title":"Med Res Arch"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.02.043","article-title":"Epigenetics of reprogramming to induced pluripotency","volume":"152","author":"Papp B","year":"2013","unstructured":"Papp B, Plath K. Epigenetics of reprogramming to induced pluripotency. Cell. 2013, 152:1324-43. 10.1016\/j.cell.2013.02.043","journal-title":"Cell"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8030288","article-title":"iPS-cell technology and the problem of genetic instability-can it ever be safe for clinical use?","volume":"8","author":"Attwood SW","year":"2019","unstructured":"Attwood SW, Edel MJ. iPS-cell technology and the problem of genetic instability-can it ever be safe for clinical use?. J Clin Med. 2019, 8:288. 10.3390\/jcm8030288","journal-title":"J Clin Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/415386-induced-pluripotent-stem-cells-ipsc-and-their-use-in-disease-modeling","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T08:08:54Z","timestamp":1759824534000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/415386-induced-pluripotent-stem-cells-ipsc-and-their-use-in-disease-modeling"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":74,"URL":"https:\/\/doi.org\/10.7759\/cureus.93999","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,7]]}}}